Caseware UK (AP4) 2023.0.135 2023.0.135 2024-06-302024-06-302025-05-13162023-07-01false15falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 11689245 2023-07-01 2024-06-30 11689245 2022-07-01 2023-06-30 11689245 2024-06-30 11689245 2023-06-30 11689245 c:Director3 2023-07-01 2024-06-30 11689245 c:Director4 2023-07-01 2024-06-30 11689245 d:Buildings d:LongLeaseholdAssets 2023-07-01 2024-06-30 11689245 d:Buildings d:LongLeaseholdAssets 2024-06-30 11689245 d:Buildings d:LongLeaseholdAssets 2023-06-30 11689245 d:FurnitureFittings 2023-07-01 2024-06-30 11689245 d:FurnitureFittings 2024-06-30 11689245 d:FurnitureFittings 2023-06-30 11689245 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-07-01 2024-06-30 11689245 d:OwnedOrFreeholdAssets 2023-07-01 2024-06-30 11689245 d:Goodwill 2023-07-01 2024-06-30 11689245 d:Goodwill 2024-06-30 11689245 d:Goodwill 2023-06-30 11689245 d:CurrentFinancialInstruments 2024-06-30 11689245 d:CurrentFinancialInstruments 2023-06-30 11689245 d:Non-currentFinancialInstruments 2024-06-30 11689245 d:Non-currentFinancialInstruments 2023-06-30 11689245 d:CurrentFinancialInstruments d:WithinOneYear 2024-06-30 11689245 d:CurrentFinancialInstruments d:WithinOneYear 2023-06-30 11689245 d:Non-currentFinancialInstruments d:AfterOneYear 2024-06-30 11689245 d:Non-currentFinancialInstruments d:AfterOneYear 2023-06-30 11689245 d:ShareCapital 2024-06-30 11689245 d:ShareCapital 2023-06-30 11689245 d:RetainedEarningsAccumulatedLosses 2024-06-30 11689245 d:RetainedEarningsAccumulatedLosses 2023-06-30 11689245 c:FRS102 2023-07-01 2024-06-30 11689245 c:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 11689245 c:FullAccounts 2023-07-01 2024-06-30 11689245 c:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 11689245 d:Goodwill d:OwnedIntangibleAssets 2023-07-01 2024-06-30 11689245 e:PoundSterling 2023-07-01 2024-06-30 iso4217:GBP xbrli:pure

Registered number: 11689245










PRIME HEALTH PARTNERS LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 JUNE 2024

 
PRIME HEALTH PARTNERS LIMITED
REGISTERED NUMBER: 11689245

STATEMENT OF FINANCIAL POSITION
AS AT 30 JUNE 2024

2024
2023
Note
£
£

Fixed assets
  

Intangible assets
 4 
958,544
1,049,961

Tangible assets
 5 
525,613
556,272

  
1,484,157
1,606,233

Current assets
  

Stocks
  
128,499
107,323

Debtors: amounts falling due within one year
 6 
340,276
335,684

Bank and cash balances
  
6,853
14,115

  
475,628
457,122

Creditors: amounts falling due within one year
 7 
(1,765,464)
(1,898,679)

Net current liabilities
  
 
 
(1,289,836)
 
 
(1,441,557)

Total assets less current liabilities
  
194,321
164,676

Creditors: amounts falling due after more than one year
 8 
(1,092,939)
(624,196)

  

Net liabilities
  
(898,618)
(459,520)


Capital and reserves
  

Called up share capital 
  
100,000
100,000

Profit and loss account
  
(998,618)
(559,520)

  
(898,618)
(459,520)


Page 1

 
PRIME HEALTH PARTNERS LIMITED
REGISTERED NUMBER: 11689245
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 30 JUNE 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the income statement in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 13 May 2025.




Dr F Entikabi
Mr J W Foreman
Director
Director

The notes on pages 3 to 9 form part of these financial statements.

Page 2

 
PRIME HEALTH PARTNERS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

1.


General information

Prime Health Partners Limited is a private company, limited by share capital, incorporated in England and Wales under registration number 11689245. The address of the registered office is Level 5A, Maple House, 149 Tottenham Court Road, London, W1T 7NF.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

The financial statements have been prepared on the assumption that the company will have the continued financial support of the shareholders. The shareholders of the company have sufficient resources to finance the company as and when the need arises.
The financial statements have been prepared on a going concern basis which is dependent on the financial support of the shareholders to ensure that the company will continue in operational existence for the foreseeable future.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
Page 3

 
PRIME HEALTH PARTNERS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

2.Accounting policies (continued)


2.3
Revenue (continued)

the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Government grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.
Grants of a revenue nature are recognised in the Income statement in the same period as the related expenditure.

 
2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.6

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.7

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the Company in independently administered funds.

Page 4

 
PRIME HEALTH PARTNERS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

2.Accounting policies (continued)

 
2.8

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.


 
2.9

Intangible assets

Goodwill

Goodwill represents the difference between amounts paid on the cost of a business combination and the acquirer’s interest in the fair value of its identifiable assets and liabilities of the acquiree at the date of acquisition. Subsequent to initial recognition, goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised on a straight-line basis to the Income statement over its useful economic life.

Other intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 The estimated useful lives range as follows:

Goodwill
-
15
years straight line

Page 5

 
PRIME HEALTH PARTNERS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

2.Accounting policies (continued)

 
2.10

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Long-term leasehold property
-
2%
over the years
Fixtures  fittings and equipment
-
20%
reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.11

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.12

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.13

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.14

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 6

 
PRIME HEALTH PARTNERS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

2.Accounting policies (continued)

 
2.15

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.


3.


Employees

The average monthly number of employees, including directors, during the year was 15 (2023 - 16).


4.


Intangible assets




Goodwill

£



Cost


At 1 July 2023
1,371,250



At 30 June 2024

1,371,250



Amortisation


At 1 July 2023
321,289


Charge for the year on owned assets
91,417



At 30 June 2024

412,706



Net book value



At 30 June 2024
958,544



At 30 June 2023
1,049,961



Page 7

 
PRIME HEALTH PARTNERS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

5.


Tangible fixed assets





Long-term leasehold property & improve-ments
Fixtures, fittings & equipment
Total

£
£
£



Cost or valuation


At 1 July 2023
469,615
230,679
700,294


Additions
-
412
412



At 30 June 2024

469,615
231,091
700,706



Depreciation


At 1 July 2023
21,327
122,695
144,022


Charge for the year on owned assets
9,392
21,679
31,071



At 30 June 2024

30,719
144,374
175,093



Net book value



At 30 June 2024
438,896
86,717
525,613



At 30 June 2023
448,288
107,984
556,272


6.


Debtors

2024
2023
£
£


Trade debtors
138,867
158,677

Other debtors
33,234
41,212

VAT repayable
19,492
40,646

Prepayments
21,452
19,907

Deferred taxation
127,231
75,242

340,276
335,684


Page 8

 
PRIME HEALTH PARTNERS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Bank loans
105,875
156,369

Trade creditors
321,151
360,681

Other creditors
211,000
140,097

Amounts owed to associated company
916,969
1,027,385

Directors' loan account
204,147
209,147

Accruals
6,322
5,000

1,765,464
1,898,679


Bank loans of £95,875 (2023 - £145,602) are secured by a fixed and floating charge over the assets of the company. Bank loan of £10,000 (2023 - £10,767) is unsecured bounce back loan received by the company.


8.


Creditors: Amounts falling due after more than one year

2024
2023
£
£

Bank loans
1,092,939
624,196

1,092,939
624,196


Bank loans of £1,083,771 (2023 - £608,933) are secured by a fixed and floating charge over the assets of the company. Bank loan of £9,168 (2023 - £15,263) is unsecured bounce back loan received by the company.


9.


Controlling party

There is no controlling party.

 
Page 9